Delivery Order SPE2DB22D2006-SPE2DB25FW3NE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhalers (60-count) on September 2, 2025, with ultimate completion by September 3, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a small-value transaction typical of routine pharmaceutical supply replenishment orders. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from its...
- The Defense Logistics Agency awarded a delivery order valued at $1,148.66 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. WIXELA is a combination inhaled medication used in respiratory disease treatment, representing a...
- The Defense Logistics Agency awarded a $2,141.04 delivery order to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price contract, which is a child order under a larger contract vehicle, involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. WIXELA is a combination inhalation medication used in respiratory therapy, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,496.16 to AmerisourceBergen Drug Corp on September 3, 2025, for WIXELA 250-50 inhaler units (60-count). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.08 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhaler units (60-count) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,378.26 delivery order to AmerisourceBergen Drug Corp for WIXELA 500-50 inhalation powder (60-count units), a combination asthma and chronic obstructive pulmonary disease maintenance medication. This firm fixed price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for WIXELA 250-50 inhalation powder (60-unit package) with a ceiling value of $1,733.01. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,030.31 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhaler units (60-count). The contract, which became effective on May 20, 2025, with completion by May 21, 2025, is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,155.90 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the prime contractor at its Conshohocken, Pennsylvania location. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3NEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,501.44 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. WIXELA is a combination inhalation medication used to treat chronic obstructive pulmonary disease and asthma. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill federal medical supply needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/15/25 |